Medical Countermeasures UK Opens Moderna mRNA Vaccine Centre in Oxfordshire and Launches £50 Million Life-Sciences FundGlobal Biodefense StaffSeptember 29, 2025
Contracts + Grants U.S. Expands Investments in Biodefense Preparedness Through New Medical Countermeasure ContractsGlobal Biodefense StaffSeptember 23, 2025
Pathogens New Study Reveals Key to Marburg and Ebola Virus Assembly, Opening Door to Broad-Spectrum AntiviralsGlobal Biodefense StaffSeptember 23, 2025
Countermeasure Development: First Ever FDA Qualification of Clinical Safety Biomarker Featured News October 29, 2018 …
SIGA, USAMRIID Enter Agreement to Evaluate Post-Exposure Prophylactic for Smallpox Medical Countermeasures October 4, 2018 …
Soligenix’s Innate Defense Regulator Selected for NIH Commercialization Transition Funding Contracts + Grants September 20, 2018 …
CDC to Award Contract to Emergent for 9 Million Doses of Smallpox Vaccine Medical Countermeasures August 12, 2018 …
Landmark Ebola Study Provides Deep Scan of Therapeutic Antibody Combinations Medical Countermeasures August 9, 2018 …
Collaboration Among BARDA, DTRA, USAMRIID and Spero to Advance SPR994 Antimicrobial Resistance July 16, 2018 …
Soligenix Receives European and Canadian Patents for Ricin Toxin Vaccine Medical Countermeasures July 12, 2018 …
MERS-CoV: Clinical Trial Starts for Regeneron’s Monoclonal Antibody Treatments Medical Countermeasures May 18, 2018 …
Army Developing Implantable Sustained-Release Malaria Countermeasure Contracts + Grants May 13, 2018 …
